SANTA MONICA, Calif., June 24, 2025 /PRNewswire/ -- EarFun, the consistently awarded wireless audio brand is debuting a new kind of wireless earbuds called...
HAUPPAUGE, N.Y., June 24, 2025 /PRNewswire/ -- Makers Nutrition, a leading provider of custom and stock dietary supplement manufacturing services, is proud to announce...
TOMS RIVER, N.J., June 20, 2025 /PRNewswire/ -- In a supplement market saturated with empty promises and low-quality formulations, Pals Health emerges as a brand committed to...
The company's fourth mission will focus on demonstrating its new satellite bus, an in-house heatshield, and solution-based pharmaceutical processing.
EL SEGUNDO, Calif., June 23,...
PALO ALTO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its Board of Directors (the “Board”) has approved a deferral of the previously announced record date of May 2, 2025 for the Company’s previously announced dividend of Scilex preferred stock (the “Dividend”) to its stockholders and certain other securityholders of Scilex. The new record date for the Dividend will be such later date to be determined in the sole discretion of the Board (such later record date as so determined by the Board, the “New Record Date”). The Board retains the right to continue to change any New Record Date (and therefore any related payment date for the Dividend) and the ability to revoke the Dividend.
Nixol introduces a new natural supplement in the United Kingdom to support metabolism, curb cravings, and promote healthy weight loss management using vegan-friendly ingredients.
Nixol introduces a new natural supplement in the United Kingdom to support metabolism, curb cravings, and promote healthy weight loss management using vegan-friendly ingredients.
Data Add to Growing Body of Evidence Demonstrating Functional and Quality of Life Improvements in Patients Treated with INGREZZA for Tardive Dyskinesia Findings Presented at...
New Coconut Cream and Orange Vanilla Swirl Flavors
LOS ANGELES, June 17, 2025 /PRNewswire/ -- Don Francisco's Coffee, the flagship premium brand of Gaviña Coffee Company,...
SHANGHAI, June 15, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the National Medical Products Administration (NMPA) has officially accepted...
IRVINE, Calif., June 12, 2025 /PRNewswire/ -- Vytanutra proudly announces the release of its newest product, Vytanutra C, Ascorbic Acid a scientifically formulated supplement designed...
- Project to Commemorate 60th Anniversary of Gacha (R)'s Introduction to Japan Kicked off Feb. 17 "Gacha's Day" -
TOKYO, June 12, 2025 /PRNewswire/ --...
STOCKHOLM, June 9, 2025 /PRNewswire/ -- Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that new data was presented at the 62nd European...